Warby Parker News

Warby Parker Analyst Ratings

BenzingaDec 16 06:18 ET

Analysts Offer Insights on Healthcare Companies: Arcutis Biotherapeutics (ARQT) and Warby Parker (WRBY)

TipRanksDec 16 01:53 ET

JMP Securities Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $28

Moomoo NewsDec 16 01:31 ET

Baird Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $30

Moomoo NewsDec 13 11:31 ET

Warby Parker Is Maintained at Hold by Stifel

Dow JonesDec 11 11:13 ET

Goldman Sachs Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $26

Moomoo NewsDec 10 11:31 ET

Warby Parker Is Maintained at Buy by Goldman Sachs

Dow JonesDec 10 09:54 ET

Warby Parker Price Target Raised to $26.00/Share From $20.00 by Goldman Sachs

Dow JonesDec 10 09:54 ET

Telsey Advisory Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $26

Moomoo NewsNov 21 09:32 ET

Warby Parker Analyst Ratings

BenzingaNov 19 12:07 ET

Telsey Advisory Maintains Warby Parker(WRBY.US) With Buy Rating, Raises Target Price to $26

Moomoo NewsNov 19 09:32 ET

Telsey Advisory Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsNov 13 09:31 ET

Telsey Advisory Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsNov 12 09:31 ET

Telsey Advisory Maintains Warby Parker(WRBY.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsNov 11 09:31 ET

A Quick Look at Today's Ratings for Warby Parker(WRBY.US), With a Forecast Between $20 to $23

Moomoo NewsNov 9 08:08 ET

Warby Parker Is Maintained at Overweight by Piper Sandler

Dow JonesNov 8 09:42 ET

Morgan Stanley Remains a Hold on Warby Parker (WRBY)

TipRanksNov 8 09:35 ET

Warby Parker Analyst Ratings

BenzingaNov 8 09:32 ET

A Quick Look at Today's Ratings for Warby Parker(WRBY.US), With a Forecast Between $19 to $23

Moomoo NewsNov 8 08:13 ET

Warby Parker's Strategic Growth and Financial Performance Earns Buy Rating From Oliver Chen

TipRanksNov 7 18:58 ET